Last week, Kaiser Medical Research's Kaiser Permanente Research Bank sent an invitation to all adult users over the age of 18 to participate in an ambitious precision medical program: in the next few years, Caesar will be The 7 regions of the service collect DNA, lifestyle and environmental information from 280,000 customers. All participants only need to provide a health questionnaire and a qualified blood sample, and allow researchers to access past and future electronic medical records.
In fact, as early as 2005, Caesar collected data from patients in California. So far, Caesar has collected health information for 220,000 users in four regions of the United States, including genetic information for SNP chip testing. In other words, Caesar is determined to build a precise medical database with at least 500,000 users and the most diverse data in the next few years.
If you read this, you may ask, is Caesar Medical the Caesar Medical known for its HMO model? The answer is yes. It is the medical giant who has 38 medical centers, 618 clinics, nearly 10 million users, and integrated insurance and medical services after more than 70 years of vicissitudes.
As we all know, Caesars Medical, as a model of the HMO model, has been committed to saving medical expenses and ensuring the continued development of insurance funds by improving the health of users. In the past, Caesar has improved user health through patient health education, lifestyle interventions, and active care. However, in today's precision medical savage, Caesars Medical is no longer satisfied with the traditional way of health maintenance.
Caesar's scientists intend to integrate data on users' health questionnaires, electronic medical records, and DNA to try to identify key factors that fundamentally affect users' health and to significantly reduce ineffective medical expenses through the implementation of precision medicine. They believe that integrating these data together can lead to major breakthroughs in the field of disease diagnosis, treatment and prevention. With this ideal in mind, Caesars Medical established the Kaiser Permanente Research Bank, a biobank that studies the relationship between disease and the environment, lifestyle and DNA.
The current research content of Kaiser Permanente Research Bank includes: cancer, prenatal and drug response.
Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried is a preparation of rabies fixed virus CTN-1V inoculated into Vero cell. After cultivation by bioreactor, harvest the virus suspension; further perform the concentration, inactivation, and purification. The vaccine is formulated by adding human albumin, dextran 40 and sucrose through freeze-drying process. The freeze-dried vaccine looks like a white crisp cake which turns into a transparent liquid after reconstitution, without any preservative. Active ingredient: inactivated rabies fixed virus. Excipients: Human albumin, dextran 40, sucrose, sodium chloride, potassium chloride, potassium phosphate monobasic, dibasic sodium phosphate. Diluent for vaccine: sterile water for injection. The specification is 0.5ml/vial after reconstitution. 1 vial (0.5ml) per single human dose. The vaccine titer should be not less than 2.5IU.
Rabies Vaccine For Human,Human Freeze Rabies Vaccine,Human Rabies Vaccine Storage,Freeze Rabies Vaccine For Humans
Changchun Zhuoyi Biological Co., Ltd , https://www.zhuoyi-bio.com